Orion will be leading presence at PCMP Frankfurt
Press Release | Orion Corporation
MAY 05, 2015
Espoo, Finland: – Leading European pharmaceutical company Orion Corporation will be a prominent presence at the forthcoming 5th Annual Pharma Contract Manufacturing and Procurement Summit, PCMP 2015, in Frankfurt.
Orion is a silver sponsor of the two-day PCMP 2015 event, which opens on May 18 at the Sheraton Frankfurt Airport Hotel and Convention Centre.
Speakers at the event will include senior directors and academics from ALK Abelló, GSK, Johnson & Johnson, University of Glasgow, McDonalds, Merck Group, Novartis and Pfizer Inc.
Refining procurement strategies
“We are delighted to continue our sponsorship and support of the Pharma Contract Manufacturing and Procurement Summit,” said Esa Nauska, Orion Corporation’s Director of Contract Manufacturing.
“The PCMP event fulfills a valuable role in sharing the strategic and in-depth knowledge that our clients need in developing more targeted procurement strategies and that we in the CMO sector all require to provide even more responsive services,” said Mr. Nauska.
High value contract manufacturing
Orion will use networking opportunities at the event to promote its innovative and high value pharmaceutical contract manufacturing services that include proprietary and generic products for human and animal health.
Orion offers pharmaceutical contract manufacturing in various dosage forms with particular expertise in hormonal semi solids and small volume parenterals.
About Orion Corporation
Orion is a globally operating developer of pharmaceuticals and diagnostic tests. The company has been innovatively building wellbeing since 1917; initially in its native Finland and now has a direct presence in 21 European countries.
Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. It is continuously developing new drugs and treatment methods.
Orion and Fermion product and service offerings involve APIs and finished dosage forms. Service offerings include high value pharmaceutical contract manufacturing services as well as a capable marketing and sales network made available for partner licensing opportunities across global markets.
Orion is a clear market leader in its main market Finland and also markets its products in more than 100 countries worldwide. The Group’s human pharmaceuticals sales organisation covers almost all key European markets. Several collaboration partners distribute Orion products in overseas markets.
All Orion manufacturing and most of its R&D operations are in Finland, with the group headquarters in Espoo, a short distance west of Helsinki. Orion employs some 3,500 people and in 2014 reported total worldwide sales of EUR 1,015 million (2013: EUR 1,007 m.). Orion A and B shares are listed on NASDAQ OMX Helsinki.
About PCMP 2015
The Pharma Contract Manufacturing and Procurement Summit was first staged in 2010 and is an event focusing on the outsourcing the manufacturing of APIs, Fill Finish and Packaging. The summit uses industry case studies, poster sessions, key speakers and round table sessions to analyse key issues surrounding sourcing and recruitment of contracting partners including risk mitigation strategies, sourcing strategies, drug security, trends in emerging markets, quality control and methods of maintaining sterile quality.
The 2015 PCMP summit is a two day event, held May 18 and 19 at the Sheraton Airport Hotel and Convention Centre in Frankfurt am Main, Germany.
This year’s conference will particularly focus on risk mitigation and ensuring security and quality in outsourcing of APIs, Fill Finish and Packaging and small-molecule drugs, as well as the emerging challenges of serialization.
More information at: http://pcmp-summit.com
Tel: +35 810 4261